INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2015. The put-call ratio across all filers is 2.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,669,548 | -18.1% | 416,002 | -0.4% | 0.02% | -11.1% |
| Q2 2023 | $26,457,250 | +1994.6% | 417,834 | +1691.3% | 0.02% | +1700.0% |
| Q1 2023 | $1,263,103 | -4.3% | 23,326 | -6.4% | 0.00% | 0.0% |
| Q4 2022 | $1,319,243 | -38.2% | 24,929 | -45.7% | 0.00% | -50.0% |
| Q3 2022 | $2,135,000 | -80.6% | 45,876 | -76.1% | 0.00% | -75.0% |
| Q2 2022 | $10,978,000 | +171.8% | 192,341 | +191.4% | 0.01% | +166.7% |
| Q1 2022 | $4,039,000 | +15.9% | 66,003 | -0.9% | 0.00% | +50.0% |
| Q4 2021 | $3,485,000 | +197.9% | 66,580 | +112.2% | 0.00% | +100.0% |
| Q3 2021 | $1,170,000 | -4.4% | 31,372 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $1,224,000 | +46.6% | 29,980 | +21.8% | 0.00% | 0.0% |
| Q1 2021 | $835,000 | +14.7% | 24,616 | +7.5% | 0.00% | 0.0% |
| Q4 2020 | $728,000 | +106.2% | 22,892 | +66.2% | 0.00% | – |
| Q3 2020 | $353,000 | -1.7% | 13,775 | -1.4% | 0.00% | – |
| Q2 2020 | $359,000 | +30.1% | 13,969 | +73.4% | 0.00% | – |
| Q4 2019 | $276,000 | +11.7% | 8,054 | +75.0% | 0.00% | – |
| Q4 2015 | $247,000 | – | 4,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |